

| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $32.5M | +19.0% |
| Cost of Revenue | $12.0M | +9.2% |
| Gross Profit | $20.5M | +25.5% |
| R&D Expense | $8.0M | -10.4% |
| SG&A Expense | $9.1M | +3.1% |
| Operating Income | -$11.7M | -23.9% |
| Pre-tax Income | -$11.6M | -55.8% |
| Income Tax | -$196K | -1206.7% |
| Net Income | -$11.4M | -53.5% |
| EPS (Basic) | -$0.23 | -43.8% |
| EPS (Diluted) | -$0.23 | -43.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | -23.5% |
| Accounts Receivable | $10.4M | +17.7% |
| Current Assets | $35.1M | -7.2% |
| Total Assets | $42.7M | -22.7% |
| Current Liabilities | $10.5M | -5.4% |
| Total Liabilities | $11.4M | -9.7% |
| Stockholders' Equity | $31.2M | -26.6% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +57.4% |
| Capital Expenditures | $70K | -89.2% |
| Investing Cash Flow | -$1.3M | -238.8% |
| Financing Cash Flow | $7K | -100.0% |
| Free Cash Flow | -$2.1M | +61.2% |